Study Identifies Gene Responsible for Chronic-to-Acute Infection Switch

By examining human tissue samples, the Georgia Institute of Technology team led by Professor Marvin Whiteley and postdoctoral researcher Pengbo Cao identified a gene responsible for the transition between chronic and acute infections caused by Pseudomonas aeruginosa. The study, published in Nature, opens doors for developing new treatments for life-threatening acute infections and provides a deeper understanding of bacterial behavior within the human body.

While extensive research has been conducted in the lab over several years, the behavior of P. aeruginosa in humans has remained largely unknown. Professor Whiteley's team took a fresh approach by directly studying human tissue samples of chronic bacterial lung and wound infections.

Using genetic sequencing techniques, the researchers measured the levels of mRNA, which encode the proteins that determine a bacterium's behavior. Surprisingly, they discovered that a specific gene, called PA1414, was expressed at remarkably higher levels in human tissue samples compared to all other genes combined. The levels of PA1414 expression were so significant that the researchers initially thought it might be an artifact of the sequencing process.

Further investigation revealed that low oxygen levels in the body, a common characteristic of bacterial infections, played a vital role in driving the high expression of the PA1414 gene. Notably, PA1414 encodes a small RNA molecule named SicX (sRNA inducer of chronic infection X) that regulates bacterial respiration under low oxygen conditions.

To validate the gene's function, the team conducted experiments on animal infection models. They found that the absence of SicX caused the bacteria to transition from chronic to acute infections, leading to systemic infection throughout the body. This discovery highlights the importance of SicX in promoting chronic localized infections.

The research findings not only provide insights into the molecular basis of the chronic-to-acute switch in Pseudomonas aeruginosa but also offer new possibilities for targeted therapies. By targeting SicX, researchers may be able to alter the lifestyle of the bacteria, making it more susceptible to antibiotic treatments and enhancing the clearance of dangerous infections. Furthermore, SicX shows promise as a potential biomarker for the chronic-to-acute switch, allowing for early detection and timely intervention.